49 results about "Respiratory difficulty" patented technology

The invention relates to the technical field of medical instruments, and particularly discloses a deep sleep maintenance algorithm for self-adaptive pressure regulation of a breathing machine, which comprises the following steps: step 1, a data acquisition and preprocessing module is connected with a pressure sensor and a flow sensor in the breathing machine to acquire a breathing pressure signal and a breathing flow rate signal of a patient in real time; 2, the data collecting and preprocessing module further conducts filtering and smoothing processing on the collected respiratory signals, noise and interference components are removed, and normalization processing is conducted on the respiratory flow rate signals; according to the breathing machine self-adaptive pressure regulation micro-awakening suppression algorithm based on the tidal volume dynamic tracking model, by dynamically tracking the tidal volume, the breathing requirement of a patient can be sensed in real time, and the pressure output of the breathing machine is self-adaptively regulated according to the change of the tidal volume; by means of the precise pressure adjusting mode, dyspnea caused by insufficient or too high pressure can be effectively avoided.

The present application belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for relieving cough and asthma, and a preparation method and application thereof. The traditional Chinese medicine composition comprises, in mass parts, perilla seed 5-15 parts, radish seed 5-15 parts, white mulberry bark 5-15 parts, orange red or processed orange red 5-15 parts, and cassia 5-15 parts. The traditional Chinese medicine composition has the effect of relieving cough and asthma, can effectively improve the clinical symptoms such as cough, expectoration and wheezing of patients with chronic obstructive pulmonary disease, promote lung rehabilitation, improve the dyspnea condition of the patients, and improve the life quality of the patients.

The present application relates to novel substituted heterocyclic carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and / or prevention of diseases and to their use for producing medicaments for the treatment and / or prevention of diseases, in particular for the treatment and / or prevention of breathing difficulties including sleep-induced breathing difficulties such as central and obstructive sleep apnoea, snoring (primary and obstructive snoring), dysphagia, peripheral and cardiac vascular disorders including diabetic microangiopathies and disorders of the peripheral and central nervous system including neurodegenerative and neuroinflammatory disorders.

The inhalation suspension preparation containing the SGC receptor stimulant comprises the SGC receptor stimulant with an effective therapeutic dose or pharmaceutically acceptable salt of the SGC receptor stimulant, and pharmaceutically acceptable auxiliary materials of the suspension preparation, the pharmaceutically acceptable auxiliary materials of the suspension preparation comprise at least one of a surfactant, a pH regulator, an osmotic pressure regulator and a metal complexing agent; the inhalation suspension preparation containing the riociguat shows good lung absorption efficiency, is beneficial to reaching the same or better treatment level by reducing the administration dosage, can directly act on a diseased region through an administration route, takes effect more quickly compared with oral administration of the riociguat, and has a good application prospect. Gastrointestinal discomfort and systemic hypotension side effects caused by gastrointestinal tract contact and absorption entering a circulatory system can be avoided, the treatment cycle of an oral dosage form dosage titration administration scheme is shortened, and a better treatment scheme is provided for relieving dyspnea and syncope symptoms of pulmonary hypertension patients treated at home.

The invention discloses a breathing difficulty degree quantitative evaluation method and system based on artificial intelligence and a medium. The method comprises the steps that breathing sound signals, basic information and medical history information of a wearer are obtained; extracting time domain features and frequency domain features in the breath sound signals based on a preset machine learning model, and analyzing and evaluating in combination with the basic information and the medical history information to obtain a current breath condition level; according to the historical breathing data and the current breathing condition grade of the wearer, whether abnormal breathing exists or not is evaluated; if yes, the current breathing condition grade is corrected according to the motion information of the wearer in the period corresponding to the breathing sound signals, and the current dyspnea grade of the wearer is obtained. The breathing sound signals are collected in real time and analyzed and evaluated by the preset machine learning model, and the historical breathing data and the motion information are combined for analysis and correction, so that the accuracy of the evaluated dyspnea grade is improved, and the breathing condition of a wearer in daily life is accurately monitored in real time from multiple dimensions.

The present invention relates to a pharmaceutical composition comprising creatine or physiologically acceptable derivatives and / or salts and or adducts thereof for use in the treatment of breathing difficulties, chest pain, body aches etc. after virus infection particularly in combination with breathing exercises. A further embodiment of the invention relates to the use of a composition comprising creatine or physiologically acceptable derivatives and / or salts and or adducts thereof as dietary supplement for preparation of a diet supporting the recovery from breathing difficulties, chest pain, body aches etc. by breathing exercises after a viral infection of the lungs or lower respiratory system.

1. Name of the designed product: Positive airway pressure therapy machine (SS100). 2. Use of the designed product: To provide help for people with breathing difficulties. 3. Design points of the designed product: In shape. 4. Picture or photo that best shows the design points: Perspective view.

A method for treatment of cardiac problems includes performing modulation of a cardiac rhythm of a patient by increasing a number of heart beats the patient during time interval with high pleural pressure relative to the number during low (negative) pleural pressure, wherein an amplitude of the modulation of the cardiac rhythm between these segments is determined by severity of a respiratory effort and lung congestion of the patient.

The present invention provides a respiratory warning device, comprising a housing, a respiratory detection device, and an alarm device. The housing is provided with an air cavity, a connecting port, and an air vent, wherein the connecting port and the air vent are connected via the air cavity. The respiratory detection device is disposed on the housing and is used to detect sound waves generated by airflow within the air cavity. The alarm device is connected to the respiratory detection device by wire or wirelessly. The present invention provides a respiratory assistance device that utilizes the aforementioned respiratory warning device. The respiratory warning device provided by the present invention has a respiratory sensing alarm function. The respiratory assistance device provided by the present invention can monitor the patient's respiratory condition in real time and trigger an alarm when the patient experiences respiratory distress, thereby alerting caregivers to promptly address the situation. The method of use of the present invention is simple, convenient, stable, and reliable.

The invention belongs to the technical field of medical ultrasonic remote monitoring, and discloses an echocardiogram remote monitoring system for a heart failure patient, which can capture acute cardiac function deterioration corresponding to paroxysmal dyspnea and postural chest distress at night in real time through a symptom pre-recognition module, an emergency level data transmission mechanism and continuous cardiac function parameter calculation; the system no longer only transmits static images, but generates a continuous cardiac function dynamic curve, and combines a causal reasoning algorithm to help doctors to clearly distinguish physiological and pathological attributes of parameter fluctuation, so that intervention delay caused by monitoring lag is avoided, a precious treatment window is won for acute cardiac function deterioration, and the risk of acute exacerbation of heart failure is reduced; based on the integrated data, the causal reasoning algorithm can quickly locate the heart failure deterioration pathogenesis, such as association between EF value decrease and anemia and renal injury, a physician does not need to manually integrate data across platforms, the time consumed for pathogenesis investigation is reduced, timely adjustment of a treatment scheme is ensured, and blind medication caused by unknown pathogenesis is avoided.

Provided is a garment capable of mitigating breathing difficulty. A garment 1 comprises a stretchable body 2 covering the front side, right and left lateral sides, and back side of a wearer from the underarms to below a portion W of a waist line. The body 2 has: a front body 3; and a back body 4 having a stretching rate in the lateral direction lower than that of the front body 3. The front body 3 and the back body 4 have a left seam 5 and a right seam 5 which are formed by sewing the front body 3 and the back body 4 on the back side of the wearer from the right and left underarms of the wearer. The proportion of the length of the front body 3 of a portion in the lateral direction at the height of the 11th and 12th ribs of the wearer on the left and right lateral sides is made larger than the proportion of the length of the front body 3 of a portion B in the lateral direction at the height of the eighth rib R8 of the wearer on the right and left lateral sides.

The present application relates to novel substituted heterocyclic carboxamides, methods of their preparation, their use alone or in combination for the treatment and / or prevention of diseases and their use for the manufacture of a medicament for the treatment and / or prevention of diseases, in particular for the treatment and / or prevention of respiratory distress, including sleep-induced respiratory distress, such as central and obstructive sleep apnea, snoring (primary and obstructive snoring); dysphagia; peripheral and cardiovascular disorders, including diabetic microangiopathy; and peripheral and central nervous system disorders, including neurodegenerative and neuroinflammatory disorders.

The present application relates to novel substituted heterocyclic carboxamides, to a method for the production thereof, to the use thereof alone or in combination for the treatment and / or prophylaxis of diseases and to the use thereof for producing medicaments for the treatment and / or prophylaxis of diseases, in particular for the treatment and / or prophylaxis of dyspnea, including sleep-induced dyspnea, including sleep-induced dyspnea, including sleep-induced dyspnea. Such as central and obstructive sleep apnea, snoring (primary and obstructive snoring); dysphagia; peripheral and cardiovascular conditions, including diabetic microangiopathy; and peripheral and central nervous system disorders, including neurodegenerative and neuroinflammatory disorders.

A compact, hands-free, oral positive expiratory pressure (PEP) device designed to optimize respiratory mechanics by providing controlled resistance during exhalation. The device slows the respiratory rate, prolongs exhalation, generates positive airway pressure, and thereby reduces breathlessness, enhances oxygenation, and expands functional lung capacity. It is particularly beneficial in conditions such as chronic obstructive pulmonary disease (COPD), tracheobronchomalacia, excessive dynamic airway collapse (EDAC), bronchiectasis, atelectasis, and acute respiratory distress syndromes, while also serving broader functions like stress reduction, cardiovascular support, and respiratory muscle training. The device is lightweight, portable, and lanyard-supported, allowing continuous availability for daily use and physical activity. Structurally, it is conical, features a primary airflow chamber, a mouth opening, and one or more resistance orifices that regulate exhalation pressure. By maintaining consistent PEP levels (ranging approximately 4-15 cm H2O), the device helps prevent airway collapse, promotes alveolar recruitment, and improves the ventilation-perfusion ratio.

The utility model relates to the technical field of sawing machines, and discloses a vertical band sawing machine, a protective assembly and a driving assembly are arranged on a working table, the protective assembly comprises a baffle fixedly arranged above the working table, a bottom plate arranged above the working table in a sliding mode, a stud fixedly arranged above the bottom plate, a pressing plate and a nut, the bottom plate is connected with the driving assembly, and the driving assembly is connected with the baffle. The baffle is located on the front side of the bottom plate, a through hole is formed in the pressing plate, the stud is inserted into the through hole to be in contact connection with the pressing plate, and the nut is screwed into the stud to be in threaded connection with the stud and located above the pressing plate. The vertical band sawing machine has the advantages of blocking chippings generated during cutting and protecting an operator, and solves the problems that an existing vertical band sawing machine generally does not have a protection function, the generated chippings possibly fly to the body of the operator, the eyes, the skin and other parts are prone to being injured, and if the chippings enter the respiratory tract, breathing is difficult.

The present invention discloses a double-tube respiratory therapy device, which relates to the field of medical technology and includes a downward pressing mechanism, which cooperates with a treatment mechanism; the downward pressing mechanism includes a bed slidably installed in a sliding pile, a return spring is provided in the sliding pile, and a rack 1 is provided on the bed, which cooperates with a drive assembly, and the drive assembly is connected to the treatment mechanism, and the treatment mechanism includes a reciprocating motion assembly; the present invention adopts a double-tube design to provide effective help for patients with difficulty in spontaneous breathing.

A method for treating a cardiac problem, the method comprising performing a regulation of a patient's heart rhythm by increasing the number of heartbeats of the patient during time intervals with high pleural pressure relative to the number of heartbeats during periods of low (negative) pleural pressure, wherein the magnitude of the regulation of the heart rhythm between these segments is determined by the patient's respiratory effort and the severity of pulmonary congestion.

The invention relates to the technical field of training devices, and particularly discloses a heart rehabilitation training device which comprises a trainer body, and a supine plate is arranged above the trainer body; the breathing mask is positioned above the supine plate; the protection mechanism is located below the supine board; the triggering mechanism is located above the breathing mask, the triggering mechanism can trigger the protection mechanism to protect the patient by pulling the breathing mask when the patient falls down in advance, and when the patient has symptoms such as dizziness and dyspnea, the patient topples over to trigger the protection mechanism through the triggering mechanism to protect the patient; when a patient topples over, the patient pulls the monitoring air pipe through the breathing mask, the protection mechanism is triggered through the triggering mechanism above the monitoring air pipe, the protection mechanism can protect the patient on the supine plate, the patient is prevented from falling off from the position above the supine plate, secondary damage to the patient and aggravation of the illness state are avoided, and use is quite safe.

The present invention relates to methods for treating patients with chronic cough with nalbuphine compositions as well as treating cough, breathlessness, or dyspnea associated with IPF with nalbuphine compositions, wherein the method provides a therapeutic effect in a patient.

The utility model relates to the technical field of atomizers, and discloses a pacifying type nipple dual-purpose mask atomizer for infants, which comprises an atomizer body, an atomizing mask is connected onto a mist outlet pipe of the atomizer body, a nipple is connected in the atomizing mask, two ends of the nipple are respectively provided with a sucking end and a fixing end, a first atomizing hole is arranged in the center of the sucking end, and a second atomizing hole is arranged in the fixing end. A second atomization hole is formed in the side face, close to the fixed end, of the nipple, a third atomization hole is formed in the inner side of the atomization mask, and the first atomization hole, the second atomization hole and the third atomization hole are all communicated with the outlet end of the atomizer body. A crying infant can be pacified through the sucking nipple, medicine is inhaled at the same time in an oral cavity inhalation mode and a nasal cavity inhalation mode, the atomization treatment time of the infant is shortened, and the risk of dyspnea caused by mucous membrane edema, airway stenosis and the like due to excessive humidification of the respiratory tract is reduced.

1. Name of the product in this design: Portable oxygen-enriched respirator. 2. Purpose of this design: To provide oxygen-enriched respirators for high-altitude tourists, patients with breathing difficulties, or the elderly and infirm. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: a 3D model.

To provide a ventilation difficulty prediction apparatus, a ventilation difficulty prediction method, and a program capable of accurately predicting the occurrence of ventilation difficulty.SOLUTION: A ventilation difficulty prediction apparatus comprises: an acquisition unit that acquires biometric data based on biometric information; and a prediction unit that predicts an occurrence of a ventilation difficulty event of a subject based on output data obtained by inputting the biometric information detected from the subject into a trained model that has been trained using training data in which the biometric data is used as input data and statistical data related to the biometric data is used as output data.SELECTED DRAWING: Figure 1

The present disclosure relates to a method and device for analyzing dyspnea, an electronic device and a storage medium. The method for analyzing dyspnea comprises: obtaining lung function data corresponding to a patient to be analyzed and / or image features corresponding to a lung image; selecting corresponding set local features from the lung function data and / or the image features, respectively; determining global features according to the lung function data and / or the image features, respectively; and fusing the set local features and the global features to obtain fused features. Based on a set classifier, the fused features are used to complete the identification or identification and / or grading of dyspnea of the patient. The present disclosure can realize the identification or identification and / or grading of dyspnea.

And treating cardiac decompensation, pulmonary hyperemia and dyspnea. A method for treating a cardiac problem, the method comprising performing modulation of the heart rhythm of a patient by increasing the number of times during time intervals with high pleural pressure relative to the number of times the patient's heartbeat during low (negative) pleural pressure, the magnitude of the regulation of the heart rhythm between these segments is determined by the patient's respiratory effort and the severity of pulmonary congestion.

Provided are compounds, methods, and pharmaceutical compositions for reducing the amount or activity of PLP1 RNA in a cell or subject, and in certain instances reducing the amount of proteolipid protein 1 in a cell or subject. Such compounds, methods, and pharmaceutical compositions are useful to ameliorate at least one symptom or hallmark of a leukodystrophy. Such symptoms and hallmarks include hypotonia, nystagmus, optic atrophy, respiratory distress, motor delays, cognitive dysfunction, speech dysfunction, spasticity, ataxia, seizures, choreiform movements, and death. Such leukodystrophies include Pelizaeus-Merzbacher disease.

The utility model discloses a variable condensate water collecting device of a breathing machine. Humidified water can be condensed in the pipeline, and condensed water can be accumulated at the lower bent position of the trachea, so that the trachea is blocked, and a patient has dyspnea. The device comprises a breathing machine (4) and an air pipe (2), a plurality of drainage heads (1) are fixed to the bottom of the air pipe in the length direction, and one drainage head is in threaded connection with a water accumulation tank (3); the drainage head comprises a sleeve (15), a sealing piece (11) and an insertion rod (12), a baffle (16) is fixed in the sleeve, the insertion rod is fixed at the bottom of the sealing piece, the insertion rod penetrates through the baffle to be fixed with a bottom plate (14), and a spring (13) is sleeved on the insertion rod. The variable condensate water collecting device is used for collecting variable condensate water of the breathing machine.

A positive expiratory pressure-generating device for reducing breathlessness in a subject with one or more pulmonary disorders is disclosed. The device is rigid and hollow and can be held in the mouth of the subject. The device has at least one air chamber, at least one opening in the portion of the device that is held in the mouth and at least one additional airflow orifice. The device is configured to increase expiratory resistance and can be supported by the mouth of the subject without the need for additional support by hands, another device or other means.

According to the invention, 1-chloro-3, 5-dibromobenzene and sodium indigo disulfonate are used as main raw materials, two medicaments respectively containing the substances are prepared, and the two medicaments react in a gas collection device to generate a gas. The gas has a special aromatic smell, and tests show that the gas does not strongly stimulate the respiratory tract, but can cause an obvious unsmooth breathing phenomenon of people, and the unsmooth breathing phenomenon lasts for a short period of time. Therefore, the gas has a certain inhibition effect on the respiratory system.

The utility model discloses a lung flute auxiliary device for discharging sputum, and relates to the technical field of sputum aspirators. The whistle comprises a shell, the surface of the shell is in threaded connection with an air nozzle, the left end of an inner cavity of the shell is in threaded connection with a connecting ring, an inner cavity of the connecting ring is fixedly connected with a whistle plate, the right end of the top of the whistle plate is provided with a vibration auxiliary mechanism, and the right side of the shell is movably connected with an air outlet adjusting mechanism. By arranging the vibration assisting mechanism, vibration assistance can be provided for a patient with dyspnea, so that the whistle plate can be knocked when the breath is weak, the whistle plate can emit low-frequency sound waves of 16-25 Hz, and the patient can be helped to clear secretions; the air output can be adjusted according to people with different vital capacities, so that the whistle plate can be blown more conveniently, and great convenience is brought to daily use.

The invention discloses an elevator emergency rescue method and an elevator integrated with an AED device, and relates to the technical field of elevators, the elevator emergency rescue method comprises the steps that AI images and sign information of passengers in a lift car are collected, the AI images comprise body discomfort information, and the sign information comprises breathing information and heart rate information; according to the A I image, whether a passenger in the car has an abnormal behavior of body discomfort or not is recognized, and a posture analysis result is generated; according to the physical sign information, whether the passengers in the lift car have dyspnea or abnormal heart rate or not is recognized, and a physical sign analysis result is generated; and judging whether an emergency rescue program needs to be started and implemented or not according to the posture analysis result and the physical sign analysis result. By the adoption of the method, whether a person has sudden cardiac arrest in the elevator car or not can be monitored in real time, and linkage of the monitoring result and the emergency rescue program of the elevator is achieved.